Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 2	2026-09-15		NCT07061535

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Innovent Biologics, Inc.	10
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences	Hangzhou	China	1
First Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	China	1
Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University	Changsha	China	1
Second Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	China	17
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science	Jinan	China	1